Lantheus Holdings Inc (LNTH)
79.59
+0.89
(+1.13%)
USD |
NASDAQ |
May 15, 16:00
79.59
0.00 (0.00%)
After-Hours: 16:06
Lantheus Holdings Price to Book Value: 5.834 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 5.769 |
| May 13, 2024 | 5.709 |
| May 10, 2024 | 5.573 |
| May 09, 2024 | 5.564 |
| May 08, 2024 | 5.462 |
| May 07, 2024 | 5.572 |
| May 06, 2024 | 5.535 |
| May 03, 2024 | 5.537 |
| May 02, 2024 | 5.731 |
| May 01, 2024 | 4.94 |
| April 30, 2024 | 4.878 |
| April 29, 2024 | 4.930 |
| April 26, 2024 | 4.806 |
| April 25, 2024 | 4.780 |
| April 24, 2024 | 4.779 |
| April 23, 2024 | 4.720 |
| April 22, 2024 | 4.622 |
| April 19, 2024 | 4.676 |
| April 18, 2024 | 4.568 |
| April 17, 2024 | 4.506 |
| April 16, 2024 | 4.524 |
| April 15, 2024 | 4.416 |
| April 12, 2024 | 4.455 |
| April 11, 2024 | 4.507 |
| April 10, 2024 | 4.387 |
| Date | Value |
|---|---|
| April 09, 2024 | 4.428 |
| April 08, 2024 | 4.378 |
| April 05, 2024 | 4.458 |
| April 04, 2024 | 4.381 |
| April 03, 2024 | 4.338 |
| April 02, 2024 | 4.314 |
| April 01, 2024 | 4.405 |
| March 31, 2024 | |
| March 28, 2024 | 5.229 |
| March 27, 2024 | 5.080 |
| March 26, 2024 | 4.936 |
| March 25, 2024 | 4.960 |
| March 22, 2024 | 4.959 |
| March 21, 2024 | 4.934 |
| March 20, 2024 | 4.972 |
| March 19, 2024 | 4.910 |
| March 18, 2024 | 4.749 |
| March 15, 2024 | 4.888 |
| March 14, 2024 | 5.027 |
| March 13, 2024 | 5.014 |
| March 12, 2024 | 5.115 |
| March 11, 2024 | 5.270 |
| March 08, 2024 | 5.253 |
| March 07, 2024 | 5.259 |
| March 06, 2024 | 5.207 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.400
Minimum
Nov 05 2020
15.28
Maximum
May 12 2023
6.327
Average
5.996
Median
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 12.22 |
| Boston Scientific Corp | 5.494 |
| Align Technology Inc | 5.612 |
| Edwards Lifesciences Corp | 7.634 |
| NeuroMetrix Inc | 0.3994 |
Price to Book Value Related Metrics
| PE Ratio | 12.15 |
| PS Ratio | 4.099 |
| Price to Free Cash Flow | 20.11 |
| Price | 79.59 |
| Earnings Yield | 8.23% |
| Market Cap | 5.517B |
| Operating PE Ratio | 11.80 |
| Normalized PE Ratio | 15.12 |